Connection

ELMER B SANTOS to Radiopharmaceuticals

This is a "connection" page, showing publications ELMER B SANTOS has written about Radiopharmaceuticals.
Connection Strength

0.324
  1. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment. Clin Cancer Res. 2021 06 01; 27(11):3253-3264.
    View in: PubMed
    Score: 0.125
  2. (124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo. J Nucl Med. 2010 Jan; 51(1):121-9.
    View in: PubMed
    Score: 0.057
  3. 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography is a sensitive method for imaging the response of BRAF-dependent tumors to MEK inhibition. Cancer Res. 2007 Dec 01; 67(23):11463-9.
    View in: PubMed
    Score: 0.050
  4. Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. J Med Chem. 2007 Nov 15; 50(23):5853-7.
    View in: PubMed
    Score: 0.049
  5. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. J Nucl Med. 2006 Jan; 47(1):140-9.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.